Biocytogen Boston Corp is a fast-growing biotech company at the forefront of innovation, equipped with broad cutting-edge technologies. Our expertise spans a wide range of therapeutic areas, including immuno-oncology , inflammatory and autoimmune diseases, neurology, cardiovascular and metabolic disorders, and more. At Biocytogen, you will have the unique opportunity to engage in both scientific and business endeavors, driving the licensing and commercialization of cutting-edge antibody assets across multiple therapeutic fields. The successful candidate will possess a strong understanding of business development and licensing and play a key role in driving strategic growth and exploring new business opportunities for the organization.
Requirements
Benefits
BIOCYTOGEN is an Equal Opportunity Employer. Employment opportunities at BIOCYTOGEN BOSTON CORP are based upon one’s qualifications and capabilities to perform the essential functions of a particular job. All employment opportunities are provided without regard to race, color religion, sex, national origin, ancestry, age, sexual orientation, gender identity and expression, veteran status, military status, disability, mental illness, genetic information, or any other characteristic protected by law. This Equal Employment Opportunity policy governs all aspects of employment, including, but not limited to, recruitment, hiring, selection, job assignment, promotions, transfers, compensation, discipline, termination, layoff, access to benefits and training, and all other conditions and privileges of employment.

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.